Biotech

All Articles

Pfizer takes $230M reached after axing neglected DMD genetics treatment

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has blown a $230 m...

AC Immune finds 'site' possible in Alzheimer's medicine records

.After much more than twenty years of service neurodegenerative health conditions, Swiss biotech AC ...

GSK drops ph. 2 HPV vaccine over absence of best-in-class possible

.GSK has broken up a phase 2 human papillomavirus (HPV) vaccination coming from its pipeline after d...

OS Treatments refiles $6M IPO to finance HER2 drug, preclinical ADCs

.Operating system Therapies will list on the NYSE American stock swap this morning using a $6.4 thou...

ALX's fizzling CD47 reaction price sends supply spiraling down

.ALX Oncology's phase 2 gastric cancer cells action rate has actually weakened. After finding its CD...

Ionis centers eye condition from intendeds of Roche-partnered prospect after data dissatisfy

.Another of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of desires, urging the...

Biogen's CEO pointed out no dangerous deals in 2023. He's ready to become bold

.While Biogen's pharma peers are searching for late-stage properties along with little bit of threat...

Instil refills pipeline in $2B biobucks handle ImmunOnco

.Instil Bio has actually been actually a biotech searching for a pipeline after it ditched its own l...

Biogen bows out Denali Alzheimer's collab

.Biogen has handed back civil rights to an early Alzheimer's health condition program to Denali Ther...

Takeda water faucets new head of US oncology business-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of considerable leadership hirings, firings ...